glp 1 drugs in development Navigating the -tides: Medication-Assisted Weight Loss on the Forefront Glucagon-like peptide-1 - Wikipedia
Description
If I want to stop, how should I come off it
The grey market carries significant risks and should be approached with extreme caution
The sources for the data on these drugs are rather patchy, making direct comparisons difficult due to incomplete data
Extreme/rapid weight loss may result in nutritional deficiencies that lead to hair loss, anemia, weak bones or increased risk of infection
